BioAtla
+$1.31 (+2.81%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell BioAtla and other stocks, options, and ETFs commission-free!
About BCAB
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021.
CEO
Jay M. Short
Employees
—
Headquarters
San Diego, California
Founded
2007
BCAB Key Statistics
Market Cap
1.64B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
133.96K
High Today
$48.76
Low Today
$45.10
Open Price
$46.31
Volume
141.54K
52 Week High
$76.63
52 Week Low
$27.15
BCAB Earnings
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 25, Pre-Market